SCHEMBL22360768

SCHEMBL22360768

Cc1nccc(-c2cn(CC(F)F)nc2-c2cnc3[nH]ccc3c2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 4/20 0.42
NUDT1 P36639 1/20 0.40
PIK3CD O00329 3/20 0.38
PIK3CA P42336 3/20 0.38
PIK3CB P42338 3/20 0.38
PIK3CG P48736 3/20 0.38
ABL1 P00519 3/20 0.38
SRC P12931 3/20 0.38
MTOR P42345 3/20 0.38
EGFR P00533 2/20 0.38
HCK P08631 2/20 0.38
KDR P35968 2/20 0.38
EPHB4 P54760 2/20 0.38
PRKDC P78527 2/20 0.38
FEN1 P39748 2/20 0.38
PARP10 Q53GL7 1/20 0.38
PARP11 Q9NR21 1/20 0.38
FYN P06241 1/20 0.38
YES1 P07947 1/20 0.38
RET P07949 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22360766 0.89 ACVR1 (0.41) ACVR1NUDT1PIK3CDPIK3CAPIK3CB
SCHEMBL2960546 0.85 BRAF (0.53) ACVR1NUDT1PIK3CDPIK3CAPIK3CB
SCHEMBL22360762 0.82 ACVR1 (0.42) ACVR1MTORKDRFEN1PARP10
SCHEMBL2639988 0.82 BRAF (0.44) ACVR1NUDT1RIPK1BRAFMAP3K14
SCHEMBL29352906 0.82 BRAF (0.44) ACVR1NUDT1RIPK1BRAFMAP3K14
SCHEMBL20574013 0.81 ACVR1 (0.42) ACVR1NUDT1MTORFEN1PIK3C3
SCHEMBL2639580 0.81 ACVR1 (0.52) ACVR1
SCHEMBL22473809 0.81 ACVR1 (0.41) ACVR1PIK3C3BRAFMAP3K14
SCHEMBL20573988 0.79 ACVR1 (0.36) ACVR1NUDT1ABL1SRCMTOR
SCHEMBL22473738 0.77 BRAF (0.44) ACVR1NUDT1PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10787443-B2 RAF-degrading conjugate compounds ZAMBONI CHEM SOLUTIONS INC. (CA) 2020-09-29 US disclosed
WO-2020168172-A1 CONJUGATE COMPOUNDS FOR THE DEGRADATION OF RAF ZAMBONI CHEM SOLUTIONS INC. (CA) 2020-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10787443-B2 RAF-degrading conjugate compounds BRAF, RAF1, ARAF ACVR1 2798/4885NUDT1 3019/4885PIK3CD 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.